ImmunoPrecise Antibodies Company
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery. ImmunoPrecise Antibodies has launched a vaccine and therapeutic antibody programme to develop a vaccine as well as antibodies against COVID-19. The company will use its B Cell Select™ and DeepDisplay™ discovery platforms to therapeutic compounds against the coronavirus.
The company has updated its research efforts and noted that it will be using the PolyTope mAb TherapyTM and EVQLV’s artificial intelligence platforms develop a COVID-19 therapy.
The company has updated its research efforts and noted that it will be using the PolyTope mAb TherapyTM and EVQLV’s artificial intelligence platforms develop a COVID-19 therapy.
Technology:
COVID
Industry:
Vaccine/Drug
Headquarters:
Canada
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership